Human Microbiome Market - Global Forecast to 2026, by Product Type (Foods, Diagnostic Devices/Kits, Drugs, and Others), by Application (Therapeutics, and Diagnostics), by Disease Indication (Gastrointestinal Disorders, Metabolic Disorders, Women Health, Cancer, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Published On : Jan 2019 |
  • Pages : 220 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Global Human Microbiome Market – Rich Product Pipeline

Human microbiome play a major role in modern healthcare, as it allows easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12, which is essential for blood coagulation.

The global human microbiome market size was valued at US$ 46,913.4 million in 2017, and is expected to exhibit a CAGR of 17.5% over the forecast period (2018 – 2026).

Figure 1. Global Human Microbiome Market Value (US$ Mn), by Region, 2017

 

Human Microbiome  | Coherent Market Insights

                                                                           Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of gastrointestinal disorder and cancer is expected to propel growth of the human microbiome market

Human microbiome boosts immunity, nutrition, and other uses. High incidence of C. difficile infection is expected to propel demand for antibiotics, prebiotics, and probiotics, which in turn is expected to drive the market growth. According to the Centers for Disease Control and Prevention in 2015, Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections in the U.S., affecting over 500,000 people and causing about 29,000 deaths each year. According to a study published in the Clinical Infectious Disease Journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI.

Similarly, according to International Agency for Research on Cancer September 2018 estimates, around 9.6 million death and 18.1 million new cases of cancer will be diagnosed in 2018.

Furthermore, introduction of probiotic may induce change in intestinal microbiota and can stabilize microbial communities, which may prevent gut inflammation, propelling growth of the human microbiome market during the forecast period. For instance, in February 2018, Dannon expanded its Activia range with the introduction of a range of low-fat yogurt drinks, Activia Dailies, in the U.S. Activia Dailies contain live and active probiotics.

Microbiome based diagnostic and therapeutic is relatively new concept which creates concern about its safety profile. Moreover, there is concern about true efficacy of microbiome-based platform. The establishment of link between dysbiosis of microbiome and disease is critical to establish clinical potential. For a microbiome-based diagnostic, establishing clinical evidence of the link between biomarkers and disease (cancer biomarkers) would be significant. This scenario presents unique set of a challenge for designing clinical trials as the lack of uniformity in microbiome in target patient pool may affect clinical trial outcomes and reproducibility.

Figure 2. Global Human Microbiome Market Share (%), by Product, 2018 and 2026

Human Microbiome  | Coherent Market Insights

                                                                  Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of obesity in Asia Pacific is expected to boost the market growth

Asia Pacific holds dominant position in the global human microbiome market, owing to high prevalence of obesity shows alterations in gastrointestinal microbiota. According to Asian Development Bank Institute (ADBInstitute), June 2017 estimates around 1 billion people in Asia and the Pacific were obese and around 40.9% of adults in the region were overweight in 2013, compared with 34.6% in 1990. Increasing focus on human microbiome therapy in treatment of cancer in the region is also expected to boost the market growth. According to Asian Pacific Journal of Cancer Prevention, February 2004, in year 2000, around 3 million new cancer cases, and around 2 million cancer deaths, and around 5.4 million people living with cancer in Asia Pacific region.

Moreover, increase in need of early detection and diagnostics of cancer is expected to boost demand for human microbiome market. For instance, in August 2014, National Center for Biotechnology Information (NCBI), stated that Colorectal Cancer (CRC) is third most commonly diagnosed malignancy globally which accounts for around half million deaths annually. The abnormality in gut microbiome in CRC, if diagnosed early can exceed survival rate around 90%.

Key Players

Major players operating in the global human microbiome market include, Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.

Human microbiome plays a major role in modern healthcare, as they allow easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12 essential for blood coagulation. Human microbiomes boosts immunity, nutrition, and others.

Market Dynamics

Increasing prevalence of C. Difficile infection (CDI) is a major factor driving human microbiome market growth. In 2010, the American Society for Microbiology, study of CDI over a 13-year period in Quebec, Canada, reported an increase in incidence from 35.6 cases per 100,000 population in 1991 to 156.3 cases per 100,000 population in 2003. According to study published in Clinical Infectious Disease journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI. Moreover, introduction of probiotic may induce change in intestinal microbiota and can stabilize microbial communities, which may prevent gut inflammation, propelling growth of the human microbiome market over the forecast period. For instance, in October 2018, BioGaia subsidiary MetaboGen introduced two new strains Faecalibacterium prausnitzii (DSM 32379) and Desulfovibrio piger (DSM 32187) for safety study. These strains are derived from human gut microbiome.

Key features of the study:

  • This report provides in-depth analysis of the human microbiome market and provides market size (US$ 46.913 million) and Compound Annual Growth Rate (CAGR 17.5 %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global human microbiome market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global human microbiome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the human microbiome market

Detailed Segmentation:

  • Global Human Microbiome Market, By Product Type:
    • Foods
      • Probiotic
      • Prebiotic
      • Medical Food
    • Diagnostic Devices/Kits
    • Drugs
    • Others
  • Global Human Microbiome Market, By Application:
    • Therapeutics
    • Diagnostics
  • Global Human Microbiome Market, By Disease Indication:
    • Gastrointestinal Disorders
    • Metabolic Disorders
    • Women Health
    • Cancer
    • Others
  • Global Human Microbiome Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Human Microbiome Market, By Geography:
    • North America
      • By Product Type:
        • Foods
          • Probiotic
          • Prebiotic
          • Medical Food
        • Diagnostic Devices/Kits
        • Drugs
        • Others
      • By Application:
        • Therapeutics
        • Diagnostics
      • By Disease Indication:
        • Gastrointestinal Disorders
        • Metabolic Disorders
        • Women Health
        • Cancer
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Foods
          • Probiotic
          • Prebiotic
          • Medical Food
        • Diagnostic Devices/Kits
        • Drugs
        • Others
      • By Application:
        • Therapeutics
        • Diagnostics
      • By Disease Indication:
        • Gastrointestinal Disorders
        • Metabolic Disorders
        • Women Health
        • Cancer
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Foods
          • Probiotic
          • Prebiotic
          • Medical Food
        • Diagnostic Devices/Kits
        • Drugs
        • Others
      • By Application:
        • Therapeutics
        • Diagnostics
      • By Disease Indication:
        • Gastrointestinal Disorders
        • Metabolic Disorders
        • Women Health
        • Cancer
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Foods
          • Probiotic
          • Prebiotic
          • Medical Food
        • Diagnostic Devices/Kits
        • Drugs
        • Others
      • By Application:
        • Therapeutics
        • Diagnostics
      • By Disease Indication:
        • Gastrointestinal Disorders
        • Metabolic Disorders
        • Women Health
        • Cancer
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Foods
          • Probiotic
          • Prebiotic
          • Medical Food
        • Diagnostic Devices/Kits
        • Drugs
        • Others
      • By Application:
        • Therapeutics
        • Diagnostics
      • By Disease Indication:
        • Gastrointestinal Disorders
        • Metabolic Disorders
        • Women Health
        • Cancer
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Foods
          • Probiotic
          • Prebiotic
          • Medical Food
        • Diagnostic Devices/Kits
        • Drugs
        • Others
      • By Application:
        • Therapeutics
        • Diagnostics
      • By Disease Indication:
        • Gastrointestinal Disorders
        • Metabolic Disorders
        • Women Health
        • Cancer
        • Others
      • By Distribution Channel:
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Enterome Bioscience* 
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Yakult Honsha Co., Ltd.
    • DuPont
    • AG Metabiomics Corporation
    • ViThera Pharmaceuticals
    • Second Genome Inc.
    • AOBiome LLC
    • Seres Therapeutics
    • uBiome, Inc.
    • Rebiotix, Inc.
    • Synthetic Biologics, Inc
    • MicroBiome Therapeutics LLC
    • Vedanta BioSciences
    • Osel, Inc.
    • Merck & Co., Inc

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Impact Analysis
    • Key Highlights
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers and Acquisitions
    • Regulatory Framework
    • Epidemiology
  4. Global Human Microbiome Market, By Product Type, 2016 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Foods
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
      • Segment Trends
        • Probiotic
        • Prebiotic
        • Medical Food
    • Diagnostic Devices/Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Human Microbiome Market, By Disease Indication, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Gastrointestinal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Metabolic Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Women Health
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
  6. Global Human Microbiome Market, By Application, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Therapeutics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Human Microbiome Market, By Distribution Channel, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Human Microbiome Market, By Region, 2018 – 2026, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016– 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2018 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • Germany
        • U.K.
        • France        
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Enterome Bioscience*
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Yakult Honsha Co., Ltd.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  DuPont
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  AG Metabiomics Corporation
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  ViThera Pharmaceuticals
        •  Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Second Genome Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AOBiome LLC
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Seres Therapeutics
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  uBiome, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  Rebiotix, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Synthetic Biologics, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • MicroBiome Therapeutics LLC
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vedanta BioSciences
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Osel, Inc.
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck & Co., Inc
        • Company Overview
        • Product Type Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 36 market data tables and 35 figures on "Human Microbiome Market - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.